Tuesday May 15, 2012
7:30 am
Main Conference Registration and Continental Breakfast
8:15 am
Chairman’s Welcome and Opening Remarks
David Detoro
Head, Global Trial Management
Merck & Co.
8:30 am
Case Study • Improve Forecasting Accuracy and Better Manage Internal Budget Variances
Julie Davis Esq.
Clinical Business Analyst, Clinical Planning and Performance
Vertex Pharmaceuticals
9:15 am
Presentation of New Tufts CSDD Research — Forecasting and Budgeting Metrics and Best Practices
Kenneth Getz
Chairman, CISCRP; Director, Sponsored Research Programs
Tufts Center for the Study of Drug Development
Rachel Yagur
Manager, Clinical Services
ClearTrial
10:00 am
Networking and Refreshment Break
10:30 am
Manage the Variables of Site Start-up to Ensure Accurate Forecasting
Adam R. Chasse MHA
Vice President, Corporate Development
RxTrials
11:15 am
Build an Impactful Patient Recruitment/Retention Plan
Kelly McKee
Manager, Global Trial Optimization
Merck & Co., Inc.
12:00 pm
Leverage Online Clinical Community Programs to Promote Collaboration and Improve Efficiency of Global Clinical Trials
Lance Hill
CEO
Within3
12:45 pm
Luncheon Hosted by: TTC llc
1:45 pm
Working Groups • Anticipate and Respond to Global Trial Launch and Execution Variables
J. Chris Houchins
Chief Operating Officer and Senior Vice President Clinical Operations
Arno Therapeutics
Lori Shields
Vice President of Data Operations
Medidata Solutions Worldwide
2:45 pm
Networking and Refreshment Break
3:15 pm
Site Survey Results • Current State of Standard of Care — Sponsor and Sites
Carley Galasso
Client Manager
TTC llc
4:00 pm
Utilize Comparable Industry Benchmarking for Protocols, Contracts and Grants
Lori Shields
Vice President of Data Operations
Medidata Solutions Worldwide
4:45 pm
Integrate Transparency Reporting in Processes for Improved Compliance
Madhu Anant M.Sc., Ph.D., RAC
Principal
A.V. Pharmaceutical Consulting
5:30 pm
Close of Day One
5:30 pm - 6:30 pm
Networking Wine & Cheese Reception
Wednesday May 16, 2012
7:30 am
Continental Breakfast
8:15 am
Chairman’s Review of Day One
David Detoro
Head, Global Trial Management
Merck & Co.
8:30 am
Case Study • Use Earned Value Analysis to Identify Cost and Time Issues Early On
Lisa R. Sanders Ph.D., R.A.C.
Senior Scientist, Clinical Strategy
Cato Research
9:15 am
Case Study • Utilize Unit-Cost-Based Budgets for Proof of Concept (POC) Studies
Ron Corey Ph.D., MBA
Chief Operating Officer
Eboo Pharmaceuticals Inc (EPI)
10:00 am
Networking and Refreshment Break
10:30 am
On-Demand Content — Overcome Common Hurdles for Meeting Budget and Timeline Expectations
Joe Popowicz
Director, Clinical Operations
Stryker Orthobiologics
Bill Row MBA, MS, CCRA
Director, Clinical Operations, North America
REGISTRAT-MAPI
11:45 am
Luncheon
1:00 pm
Three Key Elements To Planning And Managing Studies Within Partnerships
Christopher B. Erickson
Vice President, Strategic Account Leader
PAREXEL International
1:45 pm
Benefit Analysis of FTE/Contract Employee Usage to Maximize Budget
Shaun Comfort M.D.
Chief Medical Officer
ADAPTIX Clinical Solutions, LLC; Formerly of Cyberonics
2:30 pm
Panel • Incentives for Improved Trial Performance — Evaluate Team versus Individual Rewards
David Conway
Senior Director, Clinical Operations
Halozyme Therapeutics, Inc.
Bill Row MBA, MS, CCRA
Director, Clinical Operations, North America
REGISTRAT-MAPI
Donna Jarlenski PMP
Senior Director, Clinical Business Operations, Global Medicines Development & Affairs,
Vertex Pharmaceuticals
3:30 pm
